Neugeboren Edward

Grace Therapeutics, Inc. · Director

Neugeboren Edward is listed in filings as Director at Grace Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 12, 2026, including 3 public disclosures. Recent filings connect the profile to Grace Therapeutics, Inc. (GRCE) and Matinas BioPharma Holdings, Inc. (MTNB). The current snapshot covers public activity from May 2, 2025 to Jan 12, 2026. Reported amounts are shown as $38.0K to $6.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.